Search - tctmd.com

Displaying 421 - 440 of 1231

Sort: Relevancy | Date

Presentation

Final 5-Year Follow-up of an RCT of EES and PES for Coronary Revascularization in Daily Practice

Presenter: Pieter C. Smits

July 29, 2015

News Daily News

斑块消退证据对于联合使用他汀类药物与依泽替米贝的病例提出了支持

L.A. McKeown

July 29, 2015

News Industry News

Spectranetics Completes Enrollment in ILLUMENATE Pivotal Study to Assess Safety and Efficacy of Stellarex(TM) Drug-Coated Balloon Technology

July 29, 2015

News Daily News

La Evidencia de la Regresión de la Placa Avala el Uso Combinado de Ezetimibe+Estatinas

L.A. McKeown

July 29, 2015

News Industry News

First U.S. Patients Enroll in Boehringer Ingelheim's Global RE-DUAL PCI™ and RE-CIRCUIT™ Trials Evaluating Pradaxa® (dabigatran etexilate mesylate)

July 29, 2015

News Daily News

Evidence of Plaque Regression Bolsters Case for Combining Ezetimibe With Statin

L.A. McKeown

July 29, 2015

News Features

医院、介入科医生有机会避免患者不必要的再次入院

July 28, 2015

News Features

Opportunities Exist for Hospitals, Interventionalists to Stave Off Unnecessary Readmissions

July 28, 2015

News Features

Hay Oportunidades para Hospitales e Intervencionistas que Eviten Rehospitalizaciones Innecesarias

July 28, 2015

News Daily News

所用的心导管穿刺部位不影响患者受到的辐射照射

L.A. McKeown

July 27, 2015

News Industry News

Lilly Provides Update on Evacetrapib Phase 3 Trial

July 27, 2015

News Industry News

Hemostemix Enrolls 20th Participant and Treats 15th in International Clinical Trial for Critical Limb Ischemia

July 27, 2015

News Daily News

El Punto de Acceso Utilizado para las Cateterizaciones Cardíacas No Influye en la Exposición a la Radiación de los Pacientes

L.A. McKeown

July 27, 2015

News Daily News

Access Site Used for Cardiac Cath Does Not Influence Radiation Exposure for Patients

L.A. McKeown

July 27, 2015

Presentation

REVERE Trial: Randomized Evaluation of Vascular Entry Site and Radiation Exposure

Presenter: Samir B. Pancholy

July 24, 2015

Presentation

Incidence and Predictors of Unplanned Non-TLR Up to 3 Years After DES Implantation

Presenter: Mohamed Abdel-Wahab

July 23, 2015

News Industry News

Micell Technologies Announces First Patient Enrolled in Registration Trial of MiStent SES in China

July 22, 2015

News Industry News

Minneapolis Heart Institute® Physician Serves as National PI in Research Trial Aiming to Improve Outcomes for Those with Peripheral Arterial Disease

July 21, 2015

News Features

Las Sanciones de los CMS Impulsan los Intentos por Reducir las Rehospitalizaciones a los 30 Días

July 21, 2015

News Features

CMS惩罚促使各医院努力减少30天再住院

July 21, 2015

Advertisement

Final 5-Year Follow-up of an RCT of EES and PES for Coronary Revascularization in Daily Practice

斑块消退证据对于联合使用他汀类药物与依泽替米贝的病例提出了支持

Spectranetics Completes Enrollment in ILLUMENATE Pivotal Study to Assess Safety and Efficacy of Stellarex(TM) Drug-Coated Balloon Technology

La Evidencia de la Regresión de la Placa Avala el Uso Combinado de Ezetimibe+Estatinas

First U.S. Patients Enroll in Boehringer Ingelheim's Global RE-DUAL PCI™ and RE-CIRCUIT™ Trials Evaluating Pradaxa® (dabigatran etexilate mesylate)

Evidence of Plaque Regression Bolsters Case for Combining Ezetimibe With Statin

医院、介入科医生有机会避免患者不必要的再次入院

Opportunities Exist for Hospitals, Interventionalists to Stave Off Unnecessary Readmissions

Hay Oportunidades para Hospitales e Intervencionistas que Eviten Rehospitalizaciones Innecesarias

所用的心导管穿刺部位不影响患者受到的辐射照射

Lilly Provides Update on Evacetrapib Phase 3 Trial

Hemostemix Enrolls 20th Participant and Treats 15th in International Clinical Trial for Critical Limb Ischemia

El Punto de Acceso Utilizado para las Cateterizaciones Cardíacas No Influye en la Exposición a la Radiación de los Pacientes

Access Site Used for Cardiac Cath Does Not Influence Radiation Exposure for Patients

REVERE Trial: Randomized Evaluation of Vascular Entry Site and Radiation Exposure

Incidence and Predictors of Unplanned Non-TLR Up to 3 Years After DES Implantation

Micell Technologies Announces First Patient Enrolled in Registration Trial of MiStent SES in China

Minneapolis Heart Institute® Physician Serves as National PI in Research Trial Aiming to Improve Outcomes for Those with Peripheral Arterial Disease

Las Sanciones de los CMS Impulsan los Intentos por Reducir las Rehospitalizaciones a los 30 Días

CMS惩罚促使各医院努力减少30天再住院

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content